• ERT and Bioclinica are now Clario. Find out more about our new name, and why we have come together.

Your using an unsupported browser. Please update to a modern browser for a better experience.

CNS Summit

November 17, 2022
November 20, 2022
ET
The Boca Raton, 501 East Camino Real, Boca Raton, FL 33432

The CNS Summit team is excited to announce that they will bring the fun and excitement, the sense of community, discovering new technologies, meeting interesting new people and collaborating to you year round.

More than an annual event over 4 days, CNS Summit delivers programing, social events, networking, sponsorship opportunities and some of the fun – brought to you throughout the year.

The 4-Day Summit includes:

  • Two days of one-to-one networking
  • Spotlight sessions on Decentralized Trials, Artificial Intelligence, Remote Monitoring, Real World Evidence, Digital Medicine, Digital Biomarkers, Diversity, Pediatrics
  • Exhibits, posters and start-up technology
  • Collaborative conversations about the future of the industry
  • Live announcements of the annual Innovation Index with IDEA Pharma and the Innovation Showcase

Stop by our booth #38 and find out how our solutions can enrich your clinical trial data!

Session Information:

DCT Town Hall

Moderator: Craig Lipset, Advisor and Founder, Clinical Innovation Partners

Date: Saturday, November 18th, 2022  

Time: 12:00 p.m. – 2:00 p.m. EST

Additional panelists to be confirmed

Panelist

Todd Rudo headshot

Todd Rudo, MD

Chief Medical Officer at Clario

Todd Rudo, M.D. is the Chief Medical Officer at Clario. He has achieved board certifications in cardiovascular disease, cardiac electrophysiology, nuclear cardiology, adult echocardiography, and internal medicine. After 5 years in clinical medicine practicing electrophysiology and noninvasive cardiology, Dr. Rudo transitioned to a career in pharmaceutical research and development, with a focus on drug safety and pharmacovigilance. He has worked across multiple therapeutic areas within large and mid-size pharma.

In his current role with Clario, Dr. Rudo primarily serves in a consultative capacity, advising sponsors on optimal cardiac safety strategy for their development programs. This includes recommendations on protocol design, regulatory considerations, statistical analysis methodologies, and expert cardiac safety report writing. Additionally, he provides oversight of Clario’s ECG / Holter core lab services, and leadership of the biostatistics and medical writing teams. Dr. Rudo has a particular interest in leveraging novel technologies to improve the scientific rigor of clinical trials, while maintaining focus on patient burden.